반응식
[CH2:1]([O:8][CH2:9][N:10]1[C:17](Cl)=[C:16]([CH:19]([CH3:21])[CH3:20])[C:14](=[O:15])[NH:13][C:11]1=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:22]1([SeH:28])[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1.CC1C=C([SeH])C=C(C)C=1>>[CH2:1]([O:8][CH2:9][N:10]1[C:17]([Se:28][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)=[C:16]([CH:19]([CH3:21])[CH3:20])[C:14](=[O:15])[NH:13][C:11]1=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1참가 물질
4
실험 절차
The titled compound was prepared in the same manner as described in Example 34 B by using 1-[(benzyloxy)methyl]-6-chloro-5-isopropyluracil and benzeneselenol in place of 6-chloro-1-(ethoxymethyl)-5-isopropyluracil and 3,5-dimethylphenyl selenol.
출처 및 근거
- ORD 기록
- ord-0dc3eddc143148188f044e5ad33d39e2
- 출처 데이터셋
- uspto-grants-1999_03
- 특허 번호
- US05889013
연결된 노트
불러오는 중…